PharmaCyte Biotech Inc (PMCB) — Strategic Asset Allocation Index
PharmaCyte Biotech Inc (PMCB) has a Strategic Asset Allocation Index of 0.0% as of April 2026. Strategic assets (PP&E of $- plus long-term investments of $0.00) total $0.00, measured against net assets of $34.98 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See PharmaCyte Biotech Inc balance sheet independence to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
PharmaCyte Biotech Inc Strategic Asset Allocation Index (2006–2026)
This chart shows how PharmaCyte Biotech Inc's Strategic Asset Allocation Index has evolved across 17 annual periods from 2006 to 2026. As of April 2026, the index stands at 0.0%, representing strategic assets of $0.00 against net assets of $34.98 Million USD. For live market cap and overall valuation, see market cap of PharmaCyte Biotech Inc.
Annual Strategic Asset Allocation Index for PharmaCyte Biotech Inc (2006–2026)
The table below presents the year-by-year Strategic Asset Allocation Index for PharmaCyte Biotech Inc from 2006 to 2026, covering 17 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See PMCB book value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2026 | 0.0% | $0.00 | $- | $0.00 | $34.98 Million | ▼ -43.3 pp |
| 2025 | 43.3% | $22.47 Million | $- | $22.47 Million | $51.89 Million | ▲ +43.3 pp |
| 2024 | 0.0% | $0.00 | $- | $0.00 | $39.51 Million | ▼ -2.2 pp |
| 2023 | 2.2% | $1.57 Million | $- | $1.57 Million | $72.69 Million | ▲ +0.4 pp |
| 2022 | 1.7% | $1.57 Million | $- | $1.57 Million | $89.92 Million | ▼ -21.8 pp |
| 2021 | 23.5% | $1.57 Million | $- | $1.57 Million | $6.68 Million | ▼ -7.4 pp |
| 2020 | 30.9% | $1.57 Million | $- | $1.57 Million | $5.09 Million | ▼ -0.3 pp |
| 2019 | 31.2% | $1.57 Million | $- | $1.57 Million | $5.04 Million | ▲ +3.9 pp |
| 2018 | 27.3% | $1.57 Million | $- | $1.57 Million | $5.77 Million | ▲ +7.8 pp |
| 2017 | 19.4% | $1.57 Million | $- | $1.57 Million | $8.09 Million | ▼ -4.7 pp |
| 2016 | 24.1% | $1.57 Million | $- | $1.57 Million | $6.52 Million | ▼ -2.4 pp |
| 2015 | 26.5% | $1.57 Million | $- | $1.57 Million | $5.94 Million | ▲ +8.9 pp |
| 2014 | 17.6% | $1.57 Million | $- | $1.57 Million | $8.94 Million | ▼ -67.1 pp |
| 2009 | 84.7% | $2.64 Million | $2.64 Million | $- | $3.12 Million | ▲ +84.3 pp |
| 2008 | 0.3% | $23.00K | $23.00K | $- | $7.44 Million | ▲ +0.1 pp |
| 2007 | 0.2% | $8.00K | $8.00K | $- | $4.29 Million | ▲ +0.0 pp |
| 2006 | 0.2% | $7.00K | $7.00K | $- | $4.41 Million | — |